Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations.

Salvatore D, Carnovale V, Iacotucci P, Braggion C, Castellani C, Cimino G, Colangelo C, Francalanci M, Leonetti G, Lucidi V, Manca A, Vitullo P, Ferrara N.

Pediatr Pulmonol. 2019 Sep;54(9):1398-1403. doi: 10.1002/ppul.24424. Epub 2019 Jun 25.

PMID:
31237430
2.

Lung clearance index in subjects with cystic fibrosis in Italy.

Lombardi E, Gambazza S, Pradal U, Braggion C.

Ital J Pediatr. 2019 May 2;45(1):56. doi: 10.1186/s13052-019-0647-5. Review.

3.

Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy.

Terlizzi V, Mergni G, Buzzetti R, Centrone C, Zavataro L, Braggion C.

J Cyst Fibros. 2019 Jul;18(4):484-490. doi: 10.1016/j.jcf.2019.04.002. Epub 2019 Apr 18.

PMID:
31005549
4.

Quality of Life and Impact of Endoscopic Sinus Surgery in Adult Patients With Cystic Fibrosis.

Lazio MS, Luparello P, Mannelli G, Santoro GP, Bresci S, Braggion C, Gallo O, Maggiore G.

Am J Rhinol Allergy. 2019 Jul;33(4):413-419. doi: 10.1177/1945892419839260. Epub 2019 Apr 1. No abstract available.

PMID:
30931587
5.

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study.

Dolce D, Neri S, Grisotto L, Campana S, Ravenni N, Miselli F, Camera E, Zavataro L, Braggion C, Fiscarelli EV, Lucidi V, Cariani L, Girelli D, Faelli N, Colombo C, Lucanto C, Lombardo M, Magazzù G, Tosco A, Raia V, Manara S, Pasolli E, Armanini F, Segata N, Biggeri A, Taccetti G.

PLoS One. 2019 Mar 22;14(3):e0213497. doi: 10.1371/journal.pone.0213497. eCollection 2019.

6.

Two CFTR mutations within codon 970 differently impact on the chloride channel functionality.

Amato F, Scudieri P, Musante I, Tomati V, Caci E, Comegna M, Maietta S, Manzoni F, Di Lullo AM, De Wachter E, Vanderhelst E, Terlizzi V, Braggion C, Castaldo G, Galietta LJV.

Hum Mutat. 2019 Jun;40(6):742-748. doi: 10.1002/humu.23741. Epub 2019 Mar 28.

PMID:
30851139
7.

Clinical expression of cystic fibrosis in a large cohort of Italian siblings.

Terlizzi V, Lucarelli M, Salvatore D, Angioni A, Bisogno A, Braggion C, Buzzetti R, Carnovale V, Casciaro R, Castaldo G, Cirilli N, Collura M, Colombo C, Di Lullo AM, Elce A, Lucidi V, Madarena E, Padoan R, Quattrucci S, Raia V, Seia M, Termini L, Zarrilli F.

BMC Pulm Med. 2018 Dec 22;18(1):196. doi: 10.1186/s12890-018-0766-6.

8.

Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis.

Sofia VM, Surace C, Terlizzi V, Da Sacco L, Alghisi F, Angiolillo A, Braggion C, Cirilli N, Colombo C, Di Lullo A, Padoan R, Quattrucci S, Raia V, Tuccio G, Zarrilli F, Tomaiuolo AC, Novelli A, Lucidi V, Lucarelli M, Castaldo G, Angioni A.

Mol Med. 2018 Jul 27;24(1):38. doi: 10.1186/s10020-018-0041-6.

9.

Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: a survey of Italian CF centers.

Borchi B, Barao Ocampo M, Cimino G, Pizzamiglio G, Bresci S, Braggion C; Italian Cystic Fibrosis Lung Transplantation Group.

Ital J Pediatr. 2018 Jun 28;44(1):72. doi: 10.1186/s13052-018-0512-y.

10.

May the new suggested lower borderline limit of sweat chloride impact the diagnostic process for cystic fibrosis?

Cirilli N, Braggion C, Mergni G, Polizzi AM, Padoan R, Sirianni S, Seia M, Raia V, Tosco A, Pisi G, Spaggiari C, Quattromano E, Bignamini E, Brandino D, Bella S, Argentini R; ICFS Sweat Test Working Group.

J Pediatr. 2018 Mar;194:261-262. doi: 10.1016/j.jpeds.2017.11.053. Epub 2018 Jan 17. No abstract available.

PMID:
29352589
11.

S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.

Terlizzi V, Di Lullo AM, Comegna M, Centrone C, Pelo E, Castaldo G, Raia V, Braggion C.

Ital J Pediatr. 2018 Jan 3;44(1):2. doi: 10.1186/s13052-017-0443-z.

12.

The prevalence of anxiety and depression in Italian patients with cystic fibrosis and their caregivers.

Catastini P, Di Marco S, Furriolo M, Genovese C, Grande A, Iacinti E, Iusco DR, Nobili RM, Pescini R, Ragni R, Randazzo R, Risso C, Tabarini P, Braggion C, De Masi S, McGreevy KS.

Pediatr Pulmonol. 2016 Dec;51(12):1311-1319. doi: 10.1002/ppul.23566. Epub 2016 Oct 19.

PMID:
27759954
13.

Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.

de Aguiar RB, Parise CB, Souza CR, Braggion C, Quintilio W, Moro AM, Navarro Marques FL, Buchpiguel CA, Chammas R, de Moraes JZ.

Cancer Lett. 2016 Feb 28;371(2):151-60. doi: 10.1016/j.canlet.2015.11.030. Epub 2015 Dec 3.

14.

Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?

Matecki S, Kent L, de Boeck K, Le Bourgeois M, Zielen S, Braggion C, Arets HG, Bradley J, Davis S, Sermet I, Reix P; respiratory function group of the European Cystic Fibrosis Society Clinical Trial Network.

J Cyst Fibros. 2016 Jan;15(1):10-20. doi: 10.1016/j.jcf.2015.03.015. Epub 2015 Apr 15. Review.

15.

Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants.

Montagnani C, Cocchi P, Lega L, Campana S, Biermann KP, Braggion C, Pecile P, Chiappini E, de Martino M, Galli L.

BMC Infect Dis. 2015 Jan 13;15:11. doi: 10.1186/s12879-014-0734-6.

16.

Aquagenic palmoplantar keratoderma: a sign of cystic fibrosis early in life.

D'Erme AM, Braggion C, de Martino M, Greco A.

Int J Dermatol. 2014 Nov;53(11):e536-8. doi: 10.1111/ijd.12452. Epub 2014 Jul 29. No abstract available.

PMID:
25069884
17.

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion C, Lever S, Arets HG, Brownlee K, Bradley JM, Bayfield K, O'Neill K, Savi D, Bilton D, Lindblad A, Davies JC, Sermet I, De Boeck K; European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee.

J Cyst Fibros. 2014 Mar;13(2):123-38. doi: 10.1016/j.jcf.2013.09.005. Epub 2013 Dec 5. Review.

18.

Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.

Dolce D, Cariani L, Campana S, Ravenni N, Mergni G, Biffi A, Colombo C, Gagliardini R, Cirilli N, Manso E, Padoan R, Soncini E, Forte FR, D'Aprile A, Ratclif L, Amboni M, Casciaro R, Minicucci L, Borio T, Cosimi A, Vieni G, Zinnarello C, Fiscarelli E, Collura M, Pensabene T, Braggion C, Döring G, Taccetti G.

J Cyst Fibros. 2014 Jan;13(1):116-7. doi: 10.1016/j.jcf.2013.08.003. Epub 2013 Sep 7. No abstract available.

19.

Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair.

Cocchi P, Taccetti G, Montagnani C, Campana S, Galli L, Braggion C, de Martino M.

Clin Microbiol Infect. 2013 Dec;19(12):1158-62. doi: 10.1111/1469-0691.12159. Epub 2013 Feb 26. Erratum in: Clin Microbiol Infect. 2014 Jan;20(1):96.

20.

Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.

Dal Molin A, Di Massimo DS, Braggion C, Bisogni S, Rizzi E, D'Orazio C, Di Toppa MV, Alghisi F, Cristadoro S, Carnovale V, Festa G, Rampini S, Colombo C, Oneta A, Furnari ML, Calamia MA, Zunino ML, Tuccio G, Spadea V, Messore B, Grosso B, Festini F.

J Vasc Access. 2012 Jul-Sep;13(3):290-5. doi: 10.5301/jva.5000036.

PMID:
22266592
21.

Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview.

Cocchi P, Cariani L, Favari F, Lambiase A, Fiscarelli E, Gioffré FV, d'Aprile A, Manso E, Taccetti G, Braggion C, Döring G, de Martino M, Campana S.

J Cyst Fibros. 2011 Dec;10(6):407-11. doi: 10.1016/j.jcf.2011.06.005. Epub 2011 Jul 12.

22.

A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.

Crovella S, Segat L, Amato A, Athanasakis E, Bezzerri V, Braggion C, Casciaro R, Castaldo G, Colombo C, Covone AE, De Rose V, Gagliardini R, Lanzara C, Minicucci L, Morgutti M, Nicolis E, Pardo F, Quattrucci S, Raia V, Ravazzolo R, Seia M, Stanzial V, Termini L, Zazzeron L, Cabrini G, Gasparini P.

Clin Chem Lab Med. 2011 Jan;49(1):49-54. doi: 10.1515/CCLM.2011.023. Epub 2010 Nov 16.

PMID:
21077791
23.

Community-associated meticillin-resistant Staphylococcus aureus.

Taccetti G, Cocchi P, Festini F, Braggion C, Campana S.

Lancet. 2010 Sep 4;376(9743):767-8. doi: 10.1016/S0140-6736(10)61371-2. No abstract available.

PMID:
20816537
24.

Case report: cystic fibrosis, lung transplantation, and the novel H1N1 flu.

Bresci S, Borchi B, Ambu S, Taccetti G, Braggion C, Leoncini F.

Transplant Proc. 2010 Jul-Aug;42(6):2270-3. doi: 10.1016/j.transproceed.2010.05.028.

PMID:
20692461
25.

A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.

Festini F, Taccetti G, Galici V, Neri S, Bisogni S, Ciofi D, Braggion C.

Am J Infect Control. 2010 Apr;38(3):244-5. doi: 10.1016/j.ajic.2009.09.017. Epub 2010 Feb 2.

PMID:
20129701
26.

The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Braccini G, Festini F, Boni V, Neri AS, Galici V, Campana S, Zavataro L, Trevisan F, Braggion C, Taccetti G.

J Chemother. 2009 Apr;21(2):188-92.

PMID:
19423472
27.

Parenteral administration of tobramycin for pulmonary exacerbations in cystic fibrosis patients: toxicity, serum levels and efficacy.

Braccini G, Lori I, Neri AS, Festini F, Pela I, Ciuti R, Boni V, Zavataro L, Braggion C, De Martino M, Taccetti G.

J Chemother. 2009 Feb;21(1):101-4. No abstract available.

PMID:
19297282
28.

Bone mineral density in cystic fibrosis patients under the age of 18 years.

Neri AS, Lori I, Festini F, Masi L, Brandi ML, Galici V, Braggion C, Taccetti G.

Minerva Pediatr. 2008 Apr;60(2):147-54.

PMID:
18449130
29.
30.

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.

Festini F, Buzzetti R, Bassi C, Braggion C, Salvatore D, Taccetti G, Mastella G.

J Hosp Infect. 2006 Sep;64(1):1-6. Epub 2006 Jul 10. Review.

PMID:
16835001
31.

National scientific associations should have a key role in adapting and implementing standard of care guidelines in European countries.

Braggion C, Alatri F, Conese M, Festini F, Gagliardini R, Raia V, Seia M, Taccetti G; Executive Committee of the Italian Cystic Fibrosis Society.

J Cyst Fibros. 2005 Dec;4(4):271-2. Epub 2005 Oct 25. No abstract available.

32.

Prevalence and correlates of vertebral fractures in adults with cystic fibrosis.

Rossini M, Del Marco A, Dal Santo F, Gatti D, Braggion C, James G, Adami S.

Bone. 2004 Sep;35(3):771-6.

PMID:
15336615
33.

Clinicopathologic reports, case reports, and small case series: usher syndrome type 1 associated with primary ciliary aplasia.

Tosi GM, de Santi MM, Pradal U, Braggion C, Luzi P.

Arch Ophthalmol. 2003 Mar;121(3):407-8. No abstract available.

PMID:
12617715
35.

Early bronchopulmonary involvement in Crohn disease: a case report.

Valletta E, Bertini M, Sette L, Braggion C, Pradal U, Zannoni M.

BMC Gastroenterol. 2001;1:13. Epub 2001 Nov 6.

36.

Prevalence of urinary incontinence in women with cystic fibrosis.

Cornacchia M, Zenorini A, Perobelli S, Zanolla L, Mastella G, Braggion C.

BJU Int. 2001 Jul;88(1):44-8.

37.

Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.

Visca P, Cazzola G, Petrucca A, Braggion C.

Clin Infect Dis. 2001 Jan;32(1):E15-6. Epub 2000 Dec 11.

PMID:
11112669
38.

[Italian Cystic Fibrosis Registry: 10 years of activity].

Bossi A, Battistini F, Braggion C, Magno EC, Cosimi A, de Candussio G, Gagliardini R, Giglio L, Giunta A, Grzincich GL, La Rosa M, Lombardo M, Lucidi V, Manca A, Mastella G, Moretti P, Padoan R, Pardo F, Quattrucci S, Raia V, Romano L, Salvatore D, Taccetti G, Zanda M.

Epidemiol Prev. 1999 Jan-Mar;23(1):5-16. Italian.

PMID:
10356860
39.

Detection of tidal expiratory flow limitation in infants with cystic fibrosis: a pilot study.

Braggion C, Polese G, Fenzi V, Carli MV, Pradal U, Milic-Emili J.

Pediatr Pulmonol. 1998 Mar;25(3):213-5. No abstract available.

PMID:
9556014
40.

Effect of different inspiratory maneuvers on FEV1 in patients with cystic fibrosis.

Braggion C, Pradal U, Mastella G, Coates AL, Milic-Emili J.

Chest. 1996 Sep;110(3):642-7.

PMID:
8797405
41.

Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study.

Braggion C, Cappelletti LM, Cornacchia M, Zanolla L, Mastella G.

Pediatr Pulmonol. 1995 Jan;19(1):16-22.

PMID:
7675553
42.

Determinants of maximal transdiaphragmatic pressure in adults with cystic fibrosis.

Pradal U, Polese G, Braggion C, Poggi R, Zanolla L, Mastella G, Rossi A.

Am J Respir Crit Care Med. 1994 Jul;150(1):167-73.

PMID:
8025744
43.

Hemoglobin desaturation during sleep and daytime in patients with cystic fibrosis and severe airway obstruction.

Braggion C, Pradal U, Mastella G.

Acta Paediatr. 1992 Dec;81(12):1002-6.

PMID:
1290842
44.

Transcutaneous blood gas analysis during sleep and exercise in cystic fibrosis.

Pradal U, Braggion C, Mastella G.

Pediatr Pulmonol. 1990;8(3):162-7.

PMID:
2349008
45.

Exercise tolerance and effects of training in young patients with cystic fibrosis and mild airway obstruction.

Braggion C, Cornacchia M, Miano A, Schena F, Verlato G, Mastella G.

Pediatr Pulmonol. 1989;7(3):145-52.

PMID:
2797928
46.

Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis.

Braggion C, Borgo G, Faggionato P, Mastella G.

Arch Dis Child. 1987 Apr;62(4):349-56.

47.

[Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].

Braggion C, Mastella G.

Minerva Pediatr. 1985 Nov 30;37(21-22):891-6. Italian. No abstract available.

PMID:
3912659

Supplemental Content

Loading ...
Support Center